MedPath

A multicenter prospective cohort study on hepatocarcinogenesis in patients with chronic hepatitis C after sustained virological response to direct acting antivirals

Not Applicable
Conditions
Chronic hepatitis C after sustained virological response
Registration Number
JPRN-UMIN000016982
Lead Sponsor
Saga Study Group of Liver Diseases
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
300
Inclusion Criteria

Not provided

Exclusion Criteria

1) Patients with Child-Pugh class C. 2) HBsAg-positive patients. 3) Patients who have malignant neoplasm.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Disease-free survival
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath